Randomized prospective study evaluating tenofovir disoproxil fumarate prophylaxis against hepatitis B virus reactivation in anti-HBc-positive patients with rituximab-based regimens to treat hematologic malignancies: The Preblin study

BACKGROUND: Hepatitis B virus (HBV) reactivation in patients with resolved HBV infection (HBsAg negative, antiHBc positive) is uncommon, but potentially fatal. The role of HBV prophylaxis in this setting is uncertain. The aim of this study was to compare the efficacy of tenofovir disoproxil fumarate...

Descripción completa

Detalles Bibliográficos
Autores principales: Buti, María, Manzano, María L., Morillas, Rosa M., García-Retortillo, Montserrat, Martín, Leticia, Prieto, Martín, Gutiérrez, María L., Suárez, Emilio, Gómez Rubio, Mariano, López, Javier, Castillo, Pilar, Rodríguez, Manuel, Zozaya, José M., Simón, Miguel A., Morano, Luis E., Calleja, José L., Yébenes, María, Esteban, Rafael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5595327/
https://www.ncbi.nlm.nih.gov/pubmed/28898281
http://dx.doi.org/10.1371/journal.pone.0184550

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5595327/
https://www.ncbi.nlm.nih.gov/pubmed/28898281
http://dx.doi.org/10.1371/journal.pone.0184550

Ejemplares similares